Skip to main content

Table 3 Age distribution of OCEAN participants who gave up driving generally or mainly due to eyesight issues, by indication

From: Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study

  

Age group

Indication

<30

30 - <40

40 - <50

50 - <60

60 - <70

70 - <80

80 - <90

90 - <100

≥100

nAMD

n

0

4

7

39

257

996

852

99

1

Gave up driving… [n (%)]

0 (0 %)

2 (50 %)

1 (14 %)

7 (18 %)

38 (15 %)

232 (23 %)

269 (32 %)

40 (40 %)

0 (0 %)

…mainly due to eyesight [n (%)]

0 (0 %)

1 (25 %)

1 (14 %)

4 (10 %)

20 (8 %)

112 (11 %)

110 (13 %)

11 (11 %)

0 (0 %)

DME

n

1

11

31

110

172

259

63

3

0

Gave up driving… [n (%)]

0 (0 %)

2 (18 %)

4 (13 %)

23 (21 %)

40 (23 %)

55 (21 %)

18 (29 %)

1 (33 %)

0 (0 %)

…mainly due to eyesight [n (%)]

0 (0 %)

2 (18 %)

1 (3 %)

8 (7 %)

21 (12 %)

21 (8 %)

7 (11 %)

1 (33 %)

0 (0 %)

BRVO

n

0

1

8

13

38

55

21

3

0

Gave up driving… [n (%)]

0 (0 %)

0 (0 %)

0 (0 %)

2 (15 %)

5 (13 %)

10 (18 %)

5 (24 %)

3 (100 %)

0 (0 %)

…mainly due to eyesight [n (%)]

0 (0 %)

0 (0 %)

0 (0 %)

1 (8 %)

3 (8 %)

3 (5 %)

1 (5 %)

1 (33 %)

0 (0 %)

CRVO

n

0

1

1

11

19

32

15

1

0

Gave up driving… [n (%)]

0 (0 %)

1 (100 %)

0 (0 %)

2 (18 %)

3 (16 %)

4 (13 %)

3 (20 %)

1 (100 %)

0 (0 %)

…mainly due to eyesight [n (%)]

0 (0 %)

1 (100 %)

0 (0 %)

1 (9 %)

1 (5 %)

1 (3 %)

2 (13 %)

0 (0 %)

0 (0 %)